News Archive: 2008

Therapeutic Antibodies

Researchers have found that antibodies do not need a particular sugar attachment long believed to be essential to their function, a discovery that could make producing therapeutic antibodies much easier and cheaper in the future. more...

How to win the war against cancer

The power of massive, integrated programs must be brought to bear. more...

Too much of a good thing: Cells with extra chromosomes share detrimental traits

Mammalian cells with extra chromosomes share some common traits that could be exploited to develop cancer treatments, according to MIT biologists. more...

New KI computational models to individualize cancer treatment

In Cell, KI researcher describe how computer simulations can reveal the inner workings and vulnerabilities of a cancer. The results reveal new ways in which cells process chemical information and could indicate how to maximize the effectiveness of disease treatments such as chemotherapy. more...

Progress made in predicting patients' response to chemo

Koch Institute plays important role in uncovering why people react differently to chemotherapy. more...

TIME Magazine takes critical look at new trends in cancer research

KI's integrative research approach highlighted as a leading example. more...

New NIH EUREKA grant awarded to Koch Institute Faculty Member

New MEMS chip for cell sizing seen as revolutionary science. more...

Prostate cancers can escape immunity

KI researchers describe potent immuno-suppressive activity of prostate cancer microenvironment. more...

KI nano-delivery systems continue to advance

Alnylam and KI collaborators publish new research on RNAi mediated gene silencing of PCSK9, a genetically validated regulator of LDL metabolism. more...

Ahead of the curve on cancer research

MIT engineers and biologists seek to optimize potential treatments. more...

Mapping new RNA expression changes in cancer cells

Published in Science, KI researcher define novel changes in 3'UTR and microRNAs in cancer cells. more...

Langer wins Millennium Technology Prize

MIT Institute Professor Robert Langer has won the Millennium Technology Prize, the world's largest award for technology innovation. more...

Team develops safe, effective RNA interference technique

A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis. more...

Uncovering a protective role of microRNA

Snippets of genetic material that have been linked to cancer also play a critical role in normal embryonic development in mice, according to a new paper from MIT cancer biologists. more...

Groundbreaking Ceremony (Photo: Justin Knight)

MIT breaks ground for Koch institute

MIT broke ground on Friday for the new David H. Koch Institute for Integrative Cancer Research, a facility that its director, Tyler Jacks, said will usher in "the next generation in cancer research." more...